openPR Logo
Press release

Global Cancer Diagnostics Market Assessment by Opportunities, Trends and filed - Market to Be Worth CAGR 11.7% By 2024

09-18-2017 03:57 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Cancer Diagnostics Market - Industry Trends and Forecast to 2024

Global Cancer Diagnostics Market - Industry Trends and Forecast to 2024

Global Cancer Diagnostics Market, By Technology [Platform Based (Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Immunohistochemistry (IHC), Next Generation Sequencing (NGS), DNA microarrays, flow cytometry and others); Instrument Based {Imaging (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography- Computed Tomography (PET-CT), mammography and ultrasound), Biopsy}]; Applications (lung cancer, breast cancer, colorectal cancer, melanoma, and others), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa) – Industry Trends and Forecast to 2024

Request for Sample @

Global Cancer Diagnostics Market is expected to reach USD 40.10 billion by 2024 from USD 16.55 billion in 2016, at a CAGR of 11.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Cancer diagnostics market has the largest market segment in drug delivery market.

The global cancer diagnostics market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. Thermo Fisher Scientific, Inc. dominated the cancer diagnostics market, by platform based accounting for the highest market share in 2016, followed by Illumina, Inc. and Roche Diagnostics. GE Healthcare dominated the cancer diagnostics market, by imaging accounting for the highest market share in 2016, followed by Siemens Healthcare GmbH and Hologic, Inc. Other players in this market include Agilent Technologies, Abbott, Becton, Dickinson and Company, and Koninklijke Philips N.V., among others holds 24.7% of the global cancer diagnostics market in 2016.

Thermo Fisher Scientific, Inc,:

Founded in 2006 as Thermo Fisher Scientific, Inc, and head quartered in Massachusetts, U.S. is focused on developing, manufacturing and sales of medical supplies, devices, laboratory equipment and diagnostic products. The company operates through four business segments: laboratory products and services, life sciences and solutions, analytical instruments and specialty diagnostic.

Recent developments:

• In June 2017, Thermo Fisher Scientific Inc. established a partnership with the Institute Of Medical Genetics and Pathology at University Hospital Basel.
• In March 2017, Thermo Fisher Scientific Inc. introduced the QuantStudio 5 Real-Time PCR System, designed to use with HID real time PCR analysis that optimises the use by reducing the cost and increasing efficiency.

Illumina, Inc.:

Founded in 1998 and headquartered in San Diego, USA. Illumina, inc. is engaged in the development, manufacturing and market integration for analysis of genetic variation and biological function. The company operates through three business segments, namely research, applied science and clinical. The research segment includes the Molecular Biological research tool, Applied Genomics Solutions, Oncology, Microbial Genomics and Genomics in Drug Development. The Applied Science segment of company offers Forensic Genomics, Commercial Agricultural Applications, Molecular Epidemiology and Biobank Analysis Solution. The clinical segment includes Molecular Diagnostics, Reproductive and Genetic Health, Translational Research and others.

Recent Developments:
• In June 2017, Illumina Inc. announced the FDA approval of Extended RAS Panel for the evaluation of colorectal cancer from the American Cancer Society for Clinical Pathology (ASCP).
• In April 2017, Illumina Inc. reported the launch of the VeriSeq NIPT solution, based on CE-IVD marked next-generation sequencing (NGS) approach for the non invasive pre-natal testing (NIPT), also including CE-IVD marked library prep and analysis software.

Browse Report @

GE Healthcare:

Founded in 1994 and headquartered in Chicago, U.S. GE Healthcare provides transformational medical technologies and services. GE healthcare operates through three business segments healthcare systems, life sciences, and healthcare digital.

Recent Developments:

• In March 2017, GE Healthcare introduced its latest product positron emission tomography/ computed tomography IQ PET/CT in Egypt for early detection of cancer and track patient’s responses to cancer treatment.
• In March 2017, GE Healthcare launched Clariscan (gadoteric acid) at the European Congress of Radiology (ECR) meeting in Europe to detect abnormalities in the brain, spine and associated tissues.

Simens Healthcare GmbH:

Founded in 1847 and headquartered in Erlangen, Germany. Siemens Healthcare GmbH is engaged in medical technologies. The company operates through different business segments, such as medical imaging, laboratory diagnostic, point of care testing, healthcare IT services, and clinical specialities & diseases. The clinical specialties & diseases segment includes cardiology, neurology, oncology, surgery, women health and others. In oncology, Siemens Healthcare GmbH provides Imaging, Laboratory Diagnostics, Virtual MR/Ultrasound Guidance for TRUS Assisted Prostate Biopsy and others.

Recent Developments:

• In May 2016, Siemens Healthcare GmbH acquired NEO New Oncology AG. With this acquisition Siemens Healthcare will expand its portfolio with molecular testing related services and technologies for oncology and genomics

Inquiry before Buying @

Related Report

Global mHealth Solutions Market- Industry Trends and Forecast to 2024

Global mHealth Solutions Market By Product and Service [Connected Medical Devices { Clinical Devices (Vital Signs Monitoring Devices, Peak Flowmeters, Fetal Monitoring Devices, Multiparameter Trackers, Neurological Monitoring Devices, Sleep Apnea Monitors) Consumer Health Devices} mHealth Apps {Healthcare Apps (General Health & Fitness Apps, Chronic Care Management Apps, Medication Management Apps, Women’s Health Apps, Personal Health Record Apps) Medical Apps (Medical Reference Apps, Continuing Medical Education Apps, Patient Management & Monitoring Apps, Communication & Consulting Apps) mHealth Services (Remote Monitoring Services, Diagnosis & Consultation Services, Treatment Services, Healthcare System Strengthening Services, Fitness & Wellness Services, Prevention Services), Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Report Access:

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Visit Blog
Follow us on LinkedIn:

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cancer Diagnostics Market Assessment by Opportunities, Trends and filed - Market to Be Worth CAGR 11.7% By 2024 here

News-ID: 724041 • Views: 1487

More Releases from Data Bridge Market Research

Global Cosmetic Market Analysis 2019: Top Key Competitors Like L'Oréal, Avon, O …
This finest cosmetics market research report is an entire overview of the market, covering various aspects including product definition, customary vendor landscape, and market segmentation based on various parameters such as type of product, its components, type of management and geography. This report contains a deep knowledge and information on what the market’s definition, classifications, applications, and engagements are while explaining the drivers and restraints of the market which is
Hospital Acquired Infection Control Market :- Key Players are Getinge Group, STE …
The Hospital Acquired Infection Control report helps you achieve your dream of an outshining and winning business. Hospital Acquired Infection Control report also makes some important proposals for a new project of Hospital Acquired Infection Control market before evaluating its feasibility. The report provides with CAGR value fluctuation during the forecast period of 2018-2025 for the market. Hospital Acquired Infection Control market report also delivers list of the leading competitors
Mass Spectrometry Market 2019: Key Competitors are Agilent Technologies, Inc., D …
This Global Mass Spectrometry Market research report help organizations in picking up learning about what is as of now there in the market, what market anticipates, the aggressive foundation and ventures to take up to eclipse the opponents. With the utilization of extraordinary practice models and brilliant strategy for research this Mass Spectrometry Market report is created that guides organizations to reveal the best chances to thrive in the market.
Collagen Peptides Market Will Hit the CAGR Value of 7.8% by 2026 | Top Key Playe …
Global Collagen Peptides Industry 2018 Market Research Report focuses on price, sales, revenue and growth rate of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers. Second on basis of segments by manufacturers, this report focuses on the sales, price of each type, average price of Credit Insurance, revenue and market share, for key manufacturers. The Global Collagen Peptides Market is expected

All 31724 Releases

More Releases for Health

Health literacy: How to improve health behaviors
Health literacy is defined as "people´s knowledge, motivation and competences to access, understand, appraise and apply information to make judgements and take decisions in everyday life healthcare concerning disease prevention and health promotion to maintain and improve quality of life during the life course." In a new volume Anne-Kathrin Mayer and colleagues shed light on the concept of health literacy from different disciplines: psychology, educational sciences, health sciences and
GetSavvi Health - For Health Insurance Needs
GetSavvi Health offers health insurance, which includes basic and primary care at affordable prices. The company believes in the fact that South Africans are hard working and each of them deserve access to affordable and high-quality healthcare facilities and that too at affordable prices. The company desires to be a leader in the primary healthcare sector. Primary care is all about basic healthcare facilities through day-to-day benefits, which help in
Psychiatric and Mental Health Nursing 2019 will prove to be a noteworthy event, with this we cherish mental health nursing by embracing the theme, “Fore-fronting nursing care to achieve mental wellness” , and would step forward to provide an opportunity to step in and join our family, as we bring and encourage to join professionals from the following areas of Mental Health, Psychology, Nursing, Physiology, Neurology, Healthcare, Education, Business to
Health Supplements Market 2017 has announced the addition of the “Health Supplements Market in India 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. The health supplements market in India, which includes nutraceuticals, dietary and protein supplements, is expected to be worth over INR 390 billion by 2020. India currently holds a miniscule share in the global health supplement market, though this is
Consumer Health in France
Summary Consumer health posted dynamic growth in 2016. The market saw a better performance in this year compared with the CAGR registered over the review period. Consumers maintained their regular consumption of non-prescription medicines. Analgesics were regularly used to treat different types of pain, whilst cough, cold and allergy (hay fever) remedies were purchased to treat symptoms which are common during wet and rainy weather. Also, more consumers purchased vitamins and
Usability & Electronic Health Records
Recent research on electronic health record (EHR) adoption has reported that among the top barriers to adoption, usability concerns equal those of security, privacy and system-integration. User Centric, a user experience research and design firm based in Chicago, is a thought leader in how to ensure EHRs are evaluated for usability. As part of a free webinar series, Managing Director Robert Schumacher, Ph.D., will present “Usability & Electronic Health Records”